Astoria Portfolio Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-93,955
Closed -$1.94M 259
2025
Q1
$1.94M Buy
93,955
+52,609
+127% +$998K 0.66% 31
2024
Q4
$761K Buy
+41,346
New +$795K 0.27% 72
2024
Q1
Sell
-11,134
Closed -$205K 194
2023
Q4
$205K Sell
11,134
-179,429
-94% -$3.57M 0.08% 183
2023
Q3
$4.02M Sell
190,563
-103,496
-35% -$1.96M 1.94% 12
2023
Q2
$5.26M Buy
294,059
+17,721
+6% +$357K 2.04% 11
2023
Q1
$5.69M Buy
276,338
+67,077
+32% +$1.35M 2.4% 10
2022
Q4
$4.23M Buy
209,261
+64,871
+45% +$1.34M 1.98% 10
2022
Q3
$2.94M Sell
144,390
-386
-0.3% -$7.69K 2% 11
2022
Q2
$3.15M Buy
144,776
+13,491
+10% +$272K 2.3% 9
2022
Q1
$2.41M Sell
131,285
-4,994
-4% -$92K 1.88% 9
2021
Q4
$2.42M Buy
+136,279
New +$2.31M 1.92% 9

Other funds holding BTAL

Astoria Portfolio Advisors's BTAL Position: Q2 2025 in Review

Astoria Portfolio Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2025, closing a stake of 93,955 shares — an estimated $1.94M sold.

Astoria Portfolio Advisors first reported a position in BTAL in Q4 2021 and held it in 11 quarters. The position peaked at $5.69M in Q1 2023. 80 funds tracked by Wall St. Rank hold BTAL as of Q2 2025.

  • Astoria Portfolio Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2025 after selling out during the quarter.
  • Astoria Portfolio Advisors sold 93,955 AGF US Market Neutral Anti-Beta Fund shares in Q2 2025, an estimated $1.94M.
  • Astoria Portfolio Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2021 and held it in 11 quarters.
  • Astoria Portfolio Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $5.69M in Q1 2023.
  • 80 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2025.

Based on Astoria Portfolio Advisors's 13F filing for Q2 2025, filed 25 Jul 2025.